• Launched 14 critical injectable medicines since Company inception in October 2023 and remains on track to meet target of 25+ products by year-end 2025 The Ultimate Check-in Guide to A Panda-Themed AdventureAvenacy Provides Update on 2025 Strategic Priorities Ahead of 43rd Annual J.P. Morgan Healthcare Conference
Elevate Your Chinese New Year Experience in A “Pandastic” Hong Kong
| ABX | ||
| 2,739.044 | ||
| 116.5740 | 0.0445% | |
| BISNIS-27 | ||
| 381.852 | ||
| 2.0350 | 0.0054% | |
| DBX | ||
| 2,503.199 | ||
| 49.4880 | 0.0202% | |
| ECONOMIC30 | ||
| 74.662 | ||
| -0.1830 | -0.0024% | |
| ESGQKEHATI | ||
| 95.253 | ||
| 0.4450 | 0.0047% | |
| ESGSKEHATI | ||
| 95.556 | ||
| 0.4990 | 0.0052% | |
| I-GRADE | ||
| 134.094 | ||
| 0.2140 | 0.0016% | |
| AUDRP | ||
| 12,677.210 | ||
| 7.5200 | 0.0594% | |
| EURRP | ||
| 20,231.780 | ||
| -32.9400 | -0.1625% | |
| JPYRP | ||
| 115.339 | ||
| 0.1295 | 0.1124% | |
| SINRP | ||
| 14,137.390 | ||
| 4.5600 | 0.0323% | |
| USDRP | ||
| 18,069.000 | ||
| 3.0000 | 0.0166% | |
